chrisvoncsefalvay/vaers-outcomes huggingface dataset:
(That AM) pt reports had slight stiff neck before vaccine. After vaccine site hurt. Pain from shoulder blade area (L) to upper arm to elbow. No loss of motion. Ibuprofen helps somewhat. If not improved will see PMD next week.
Mucus buildup in throat, which briefly constricted airway. Cleared up after about 15 minutes. No medical treatment required.
hives, shortness of breath- 3/24/2021 fever, malaise, nausea, dizziness, pruritus, migraine- 3/24/2021-3/28/2021 use of epipen for hives and shortness of breath within first 2 hours after receiveing first dose of vaccine on 03/24/2021.
Systemic Reaction  Left arm and left leg numbness presented first day, but resolved within 24 hours Shoulder, knees, elbow ankle burning pain (she believes was nerve and joint related pain, and reported 10/10 pain) presented few weeks later. Patient reported this intense pain continued but improved over few months time.
p/vax pt exp bull's-eye rash at inj site; runny nose; itchy throat; watery eyes; difficulty breathing (shortness of breath); sore lt arm; arthralgia; stiff neck; condition ongoing but improved
This spontaneous report was received from a registered nurse and refers to a 1-year-old patient of unknown gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 15-SEP-2018, the patient was vaccinated with a dose of ROTATEQ orally exact (dose, lot number, expiration date were not provided) for prophylaxis (product administered to patient of inappropriate age). No adverse effects was reported.
A report received from a health professional on 11/06/2002, concerning a 61 year old female vaccinee who experienced headache and diziness within 1 hour of receiving Fluvirin, and chest pain 3 days after receiving Fluvirin on 10/30/2002. On 10/30/2002, the vaccinee experienced headache and dizziness within 1 hour of receiving Fluvirin.  On 11/02/2002, the vaccinee experienced chest pain and was admitted to the emergency room for observation for 12 hours.  The ER physician indicated that the chest pain was associated with arthritic symptoms secondary to Fluvirin.  The vaccinee was treated with an anti-inflammatory agent and discharged home.  The symptoms resolved. There was insufficient information to determine the reporter's causality assessment. Cross reference with PJP-2002-7007 and PJP-2002-00708.
Dizziness, Headache, Diarrhea, brain fog, burning in shoulders,  Narrative:
This spontaneous report as received from a healthcare worker (medical assistant, M.A.) refers to a patient of unknown age and gender. Pertinent medical history and drug reactions or allergies were not specified. On 09-MAY-2014, the patient was vaccinated with a dose of ROTATEQ, oral (dose number, dose, frequency and lot number were not specified), which was stored outside the temperature ranges specified in the product information (PI) (exact temperatures and dates not specified). Concomitant medications were not specified. No adverse effects were reported. No product quality complaint (PQC) was reported. This is one of several reports received from the same reporter. Additional information has been requested.
patient (medical director of Nursing Center) reported on 1/25/21 that after receiving the first dose on 12/28/20, two weeks later he developed two areas with swollen lymph nodes. Both areas occurred on the left arm which is the arm in which the first COVID19 vaccine was administered.  The swollen areas lasted one week then resolved.
She has a red circle on her right arm; She has a red circle on her right arm, it hurts and it's painful.; right arm is red and hurts; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 24Oct2023 as dose 1, single (Lot number: HF9300) at the age of 71 years, in right arm for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 24Oct2023 as dose number unknown, single (Batch/Lot number: unknown), in left arm for immunisation. The patient had no relevant medical history. The patient took concomitant medications. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 3; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 4; MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious) with onset Oct2023, outcome "unknown", described as "right arm is red and hurts"; VACCINATION SITE PAIN (non-serious) with onset 25Oct2023, outcome "unknown", described as "She has a red circle on her right arm, it hurts and it's painful."; VACCINATION SITE MACULE (non-serious) with onset 26Oct2023, outcome "unknown", described as "She has a red circle on her right arm". Therapeutic measures were not taken as a result of vaccination site erythema, vaccination site pain, vaccination site macule.  Additional information: The patient got a flu shot in her left arm and the COMIRNATY shot in the right arm on 24Oct2023 at the doctor's office. Her right arm was red and hurts. She had a red circle on her right arm, it hurts and was painful. After she got the COMIRNATY shot, after a day or so it started being really painful. Today is when she noticed the red circle on her arm. With the flu shot, she did not have any reaction. She did not know if it was a side effect or not. Just wanted to know if she needed to call her doctor about it.
The patient is here with a day of severe left shoulder pain.  This started immediately after he got his Tdap and MenQuadfi shots.  It appears that he got his shots pretty high up, a lot closer to the acromion then mom would expect.  Mom is an RN.  The pain has been significant, 8 out of 10 or higher all night and nothing has really helped.  He has had 1000 of Tylenol and 600 of ibuprofen and that has not touched it.  He barely slept all night.  He is usually decently tough and is out of his mind with pain right now.  There were no other activities or trauma or possible injuries.  No fevers.  No redness or the joint.  He can move it with full range of motion but it hurts a lot.
chills, fever (99.5), headache, body ache, pain in the arm, tiredness. Those adverses events last 24 hours.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. In 2016 (report as from starting from 17-JUN-2016), the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # L007560, expiration date 15-JUN-2017; lot # L037554, expiration date 25-DEC-2017; lot # L048237, expiration date 08-MAY-2017 (dose and route of administration were not reported). There was no adverse effect reported. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
diluent had previously expired with no reported adverse event; dose of ACTHIB was administered to a patient. The powder portion was within date. the diluent had previously expired with no reported adverse event; Initial information received on 19-Dec-2022 regarding an unsolicited valid  non-serious case received from other health professional.  This case involves a 2 months old Infant  male patient who experienced diluent had previously expired with no reported adverse event and dose of acthib was administered to a patient. the powder portion was within date. the diluent had previously expired with no reported adverse event after receiving vaccine HIB (PRP/T) VACCINE [ACT-HIB].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included rotavirus vaccine  ,pneumococcal vaccine 13v  ,diphtheria vaccine toxoid, hepatitis b vaccine rhbsag (yeast), pertussis vaccine acellular 3-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (PEDIARIX) for Prophylactic vaccination.  On 19-Dec-2022, the patient received a (dose 1)suspect HIB (PRP/T) VACCINE(Dose-0.5mL)(Frequency-Total)( Powder Lot # UJ635AA, Expiration date: 27JAN2023 ,Diluent Lot #U7178AD, Expiration date: 30NOV2022)(Formulation- Powder and solvent for solution for injection)( Strength = standard) via intramuscular route in right leg for Immunization  On 19-DEC-2022 the patient developed a non-serious  events diluent had previously expired with no reported adverse event (expired product administered)and dose of acthib was administered to a patient. the powder portion was within date. the diluent had previously expired with no reported adverse event (product preparation error) following the administration of HIB (PRP/T) VACCINE.(Latency- same day)  It was reported Treatment: The caller was not aware of any treatment required post administration. If baby was delivered: delivery date and if baby experienced an adverse event Inform that they will be receiving a follow up questionnaire If calling specifically about being added to the pregnancy registry: all pregnancy cases are added to the registry, it is a requirement.  Action taken : Not applicable.  At time of reporting, the outcome was Unknown for both events  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Arm, Buttocks, back and leg rash    irritated by heat and will still not go away after treatment. currently taking allegra and benedryl
Nausea, muscle spasm lasting 3-4 hours evening of 11/11/09; nausea next day all symptoms resolved within 24 hours.
Client reports developing cold sweats, general achiness beginning 11:00 pm of 1/12/11. Started oral Typhoid at 4:00 pm 1/12/10. On 1/14/11 client began having nausea which continued through 1/17/11 along with cold sweats. All symptoms resolved by 1/18/11. On 1/19/11 received TWINRIX #2 without adverse sx. Reported lot # AHABB189AB (R) arm.
Chills, fever approx. 100 degrees, runny nose, chest congestion, coughing, extreme fatigue, dizziness.
After receiving vaccine and walking out clinic, patient stumbled, falling against door and to floor. Did not lose consciousness, reported feeling "lightheaded." Patient was placed on exam table in lying position with legs elevated. Provided water. After several minutes patient felt better to sit up. Fully recovered and stable on discharge. After event patient did report similar reactions in the past to blood draws but never a vaccine. Patient did report after the fact that he was nervous coming in.
Received first vaccine 2/25/21 unknowingly 4 weeks pregnant with no adverse reactions other than pain and bruising at the site of injection. OB confirmed okay to receive second injection. Upon waking arm was bruised and sore and felt overall ill.  Within a few hours symptoms were similar to migraine with sound and light sensitivity, nausea, fever, chills, feeling hot and cold at the same time, sweating excessively. Waited 24 hours to take Tylenol when fever reached 100.6. Currently 7 weeks 5 days pregnant. Estimated due date 11/09/2021. Most symptoms subsided within 24 hours. Dizziness and nausea is lingering longer.
This spontaneous report was received from a licensed practical nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 05-SEP-2017, the patient was vaccinated with improperly stored dose of GARDASIL 9 lot# N007931 and expiration date 17-NOV-2019 (dose, frequency and route of administration were not reported). There were no adverse effects reported. Administered dose of vaccine experienced the temperature excursion from 32 to 35 degrees Fahrenheit for 8 hours 45 minutes. Previously, there was also temperature excursion from 44 to 77 degrees Fahrenheit for 55 hours. Data loger was involved.
After injection she felt tingly and burning in her lips.  Requested benedryl no rash swelling or other complaints.
Only arm soreness the first 2 days.   Headaches on Feb. 25th, 26th.  Headaches on Feb. 4th, 5th, 6th, 7th, 8th.  The headache pain increased on 6th, 7th, 8th.  Went to ER on 7th, had CT that came out clear.   Got a COVID test because of icky taste after eating sweet foods.  COVID test was negative but I was positive for antibodies.   At 9:00 on Feb. 8th, noticed facial weakness on right side.   Went to ER, got diagnosed with Bells Palsy.  Symptoms have continued through now - March 7th.   Pain has decreased but still have facial paralysis on the right side.
Immediately site of shingles injection got red, itchy, 2-3 tiny little hives appeared showed nurse/doctor before leaving. They said it was ok to go home and take BENADRYL. Next morning was fine but by night area was itchy, hard, swollen, hot to the touch, area shaped like an oval (2 1/2" by 2"). Called nurse line who advise to take BENADRYL. Continued taking BENADRYL over the weekend. Area got worse over time, got bigger especially at night time. It was better by Monday. Since then, has developed isolated hives in different areas of body at different times. Hive on right breast, right torso above hip area, right forearm. The hive in forearm still is itchy but healing. Still has shadow of redness in injection area. Doctor mentioned that must have reacted to preservative. Area is periodically itchy/sensitive.
hot to touch; tight; itch a little; rash around the area; Rash is a bit redder; pain; Soreness around the muschle; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE WARMTH (hot to touch), SKIN TIGHTNESS (tight), VACCINATION SITE PRURITUS (itch a little), MYALGIA (Soreness around the muschle) and VACCINATION SITE RASH (rash around the area) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced MYALGIA (Soreness around the muschle) and VACCINATION SITE PAIN (pain). On 21-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot to touch), SKIN TIGHTNESS (tight), VACCINATION SITE PRURITUS (itch a little), VACCINATION SITE RASH (rash around the area) and VACCINATION SITE ERYTHEMA (Rash is a bit redder). The patient was treated with IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (hot to touch), SKIN TIGHTNESS (tight), VACCINATION SITE PRURITUS (itch a little), MYALGIA (Soreness around the muschle), VACCINATION SITE RASH (rash around the area), VACCINATION SITE ERYTHEMA (Rash is a bit redder) and VACCINATION SITE PAIN (pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
PT came into the clinic w/ rash on arms, chest, and back. over the weekend moved to legs. use calamine lotion. Pt came to the clinic on 01/13/2020 Provider gave cetirizine tablets
COVID breakthrough. Patient presented to the hospital for labor and delivery on 1/24/22. Tested for COVID routinely and found to be positive.
Vaccine frozen rather than refrigerated. Dose administered. Offered revaccination. Will receive booster
Syncope, tachycardia, chest pain, began around 2:30am with syncope episode,  tachycardia and progressive chest pain followed, seen in ED for symptoms, treated with Tramadol and fluid bolus, referred for follow up
This spontaneous report received from Nurse practitioner via company representative refers to a female patient of an unknown age. Patient concurrent and medical history was not reported. On an unknown date, the patient was vaccinated with GARDASIL (start date, dose, therapy route lot# unspecified). Dose and lot information were not provided. The patient was administered an unknown number of doses of GARDASIL on unspecified dates and patient was recently admitted to an unspecified hospital. The symptoms and diagnosis were not provided. Reporter's causality was not provided. Additional information has been requested.
Large dark bruise. Pain radiating from site of vaccine up to patient's head. Patient has fever, feels "off".
Low grade fever; Left arm is swollen/Puffy arm; Soreness in arm; Headache; Fatigue; This spontaneous case was reported by an other health care professional and describes the occurrence of HEADACHE (Headache), FATIGUE (Fatigue), PYREXIA (Low grade fever), PAIN IN EXTREMITY (Soreness in arm) and PERIPHERAL SWELLING (Left arm is swollen/Puffy arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced HEADACHE (Headache), FATIGUE (Fatigue) and PAIN IN EXTREMITY (Soreness in arm). On 07-Jan-2021, the patient experienced PYREXIA (Low grade fever) and PERIPHERAL SWELLING (Left arm is swollen/Puffy arm). At the time of the report, HEADACHE (Headache), FATIGUE (Fatigue), PYREXIA (Low grade fever), PAIN IN EXTREMITY (Soreness in arm) and PERIPHERAL SWELLING (Left arm is swollen/Puffy arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Treatment for the events was ibuprofen.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
04/10/2021 09:00PM- Patient started experiencing extreme pain neck and head excursion nerve damage feeling, then went to the hospital because he thought his head would explode. He did an MRI and was given drugs to relieve pain and he was disoriented for a day or so, hospital visit lasted 3-4 hours, released from hospital. Then two days later 04/12/2021, patient experienced radiating to lower back, hips, legs, and feet and new condition. For after the vaccination and patient was not mobile, 8 days in this condition, suffered through it. Went to another two weeks later, doctor OBGYN  and surgeon who prepared him for the next vaccination with aspirin and steroids.
THERE WAS NO ADVERSE EVENT. *******THIS WAS A VACCINE ADMINISTRATION ERROR.******* THE PATIENT COMPLETED THE ASTRA ZENECA SERIES AND REQUESTED A PFIZER BOOSTER. THE BOOSTER WAS GIVEN TOO SOON. THE ASTRA ZENECA SERIES WAS COMPLETED ON 10/06/2021.  PATIENT WAS INFORMED AND GIVE THE APPROPRIATE  INFORMATION FROM THE VACCINE ERRORS AND DEVIATIONS GUIDELINE RESOURCE: WILL NOT REPEAT DOSE
clinic experienced a temperature excursion with Pediarix and FluLaval QIV vaccines on 04May2023 that lasted 45 minutes and reached a low temperature of -0.8C.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in a 6-month-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number 25L52, expiry date 28-MAR-2025) for prophylaxis.   Co-suspect products included Flu Seasonal QIV (FluLaval Quadrivalent 2022-2023 season) (batch number 7X574, expiry date 30-JUN-2023) for prophylaxis.   On 05-MAY-2023, the patient received Pediarix and FluLaval Quadrivalent 2022-2023 season. On an unknown date, an unknown time after receiving Pediarix and FluLaval Quadrivalent 2022-2023 season, the patient experienced incorrect storage of drug (Verbatim: clinic experienced a temperature excursion with Pediarix and FluLaval QIV vaccines on 04May2023 that lasted 45 minutes and reached a low temperature of -0.8C.). The outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 11-May-2023 The pharmacist reported that a clinic experienced a temperature excursion with Pediarix and FluLaval QIV vaccines one day prior to the reporting date that lasted 45 minutes and reached a low temperature of minus 0.8 Celsius. At the time of reporting, the dose had not been repeated. The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up. The patient received a dose of Pediarix and FluLaval QIV vaccines after temperature excursion, which led to incorrect storage of drug.
"Feeling Sick"; Positive COVID-19 Test; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS ("Feeling Sick") and COVID-19 (Positive COVID-19 Test) in a 44-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced COVID-19 (Positive COVID-19 Test). On an unknown date, the patient experienced ILLNESS ("Feeling Sick"). At the time of the report, ILLNESS ("Feeling Sick") and COVID-19 (Positive COVID-19 Test) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Chills; Fever; body aches; Headache/her head hurt too bad; This is a spontaneous report from a contactable consumer (patient). A 78-years-old female patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6205; Expiration Date: 30Jun2021) via an unspecified route of administration on 10Mar2021 at 14:00 (at the age of 78-years-old) as dose 2, single for COVID-19 immunisation. The patient medical history was not reported. concomitant medications included normal vitamins. Historical vaccine included bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EL9266; Expiration Date: 31May2021) via an unspecified route of administration administered in left arm on 17Feb2021 (at the age of 78-years-old) as dose 1, single for COVID-19 immunisation. Patient also took Pneumonia booster and she had swelling in the arm on unspecified date. . Additional vaccines administered on same date of the Pfizer Suspect was reported as none. Prior Vaccinations (within 4 weeks) was reported as none. On 11Mar2021 the patient experienced chills, fever, body aches, headache/her head hurt too bad, and it was too much stress to look up addresses and stuff. Everything was fine last night but all of the patients symptoms started early this morning. The patients fever is now 101.5. The patient underwent lab tests and procedures which included body temperature 101.5 on unknown date in 2021. Outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 04/25/21pfizer,Lot# ER8736 2nd dose: 05/16/21Pfizer,Lot# EW0185 Diagnosed covid positive:07/11/21 Exposure;community. Symptoms:Runny nose, loss of smell,watery eyes.